Divi’s Laboratories Limited has reported a 23% year-on-year growth in its consolidated net profit at Rs 662 crore for the quarter ended March 31, 2025, compared to Rs 538 crore in the same quarter last year. The strong profit performance was driven by higher sales and improved operational efficiency.
Revenue from operations for the quarter rose 12% YoY to Rs 2,585 crore, up from Rs 2,303 crore in the corresponding quarter last year. Total income for the period increased to Rs 2,671 crore, compared to Rs 2,382 crore in the year-ago period.
The company’s EBITDA for the quarter stood at Rs 869 crore, reflecting a year-on-year increase from Rs 808 crore. The EBITDA margin improved to 32.5% in Q4 FY25, compared to 33.9% in the same quarter last year, indicating a stable operational performance.
Total expenses rose to Rs 1,807 crore from Rs 1,669 crore last year, led by higher material and employee costs. Profit before tax for the quarter was Rs 864 crore, up from Rs 713 crore in the same period a year ago.
For the full fiscal year FY25, Divi’s Laboratories reported a net profit of Rs 2,191 crore, a growth of 37% from Rs 1,600 crore posted in the previous year. Total income for the year was Rs 9,712 crore, compared to Rs 8,184 crore in FY24.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash